These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33036243)

  • 1. High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection.
    Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Katz MHG; Takabe K
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.
    Oshi M; Patel A; Le L; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
    Am J Cancer Res; 2021; 11(6):3070-3084. PubMed ID: 34249445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer.
    Oshi M; Takahashi H; Tokumaru Y; Yan L; Rashid OM; Matsuyama R; Endo I; Takabe K
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
    Oshi M; Tokumaru Y; Patel A; Yan L; Matsuyama R; Endo I; Katz MHG; Takabe K
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes.
    Chida K; Oshi M; An N; Kanazawa H; Roy AM; Mann GK; Yan L; Endo I; Hakamada K; Takabe K
    Am J Cancer Res; 2024; 14(1):355-367. PubMed ID: 38323295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+/HER2- breast cancer.
    Oshi M; Roy AM; Yan L; Sasamoto M; Tokumaru Y; Wu R; Yamada A; Yamamoto S; Chishima T; Narui K; Endo I; Takabe K
    Am J Cancer Res; 2023; 13(7):3041-3054. PubMed ID: 37559984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma.
    Ramos-Santillan V; Oshi M; Nelson E; Endo I; Takabe K
    World J Oncol; 2024 Apr; 15(2):257-267. PubMed ID: 38545476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
    Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.
    Oshi M; Gandhi S; Yan L; Tokumaru Y; Wu R; Yamada A; Matsuyama R; Endo I; Takabe K
    Breast Cancer Res Treat; 2022 Jul; 194(2):231-241. PubMed ID: 35639264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma.
    Wang Z; Zheng Z; Wang B; Zhan C; Yuan X; Lin X; Xin Q; Zhong Z; Qiu X
    Heliyon; 2024 Apr; 10(7):e29289. PubMed ID: 38617927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
    Neoptolemos JP; Stocken DD; Dunn JA; Almond J; Beger HG; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Lacaine F; Buckels J; Deakin M; Adab FA; Sutton R; Imrie C; Ihse I; Tihanyi T; Olah A; Pedrazzoli S; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Ann Surg; 2001 Dec; 234(6):758-68. PubMed ID: 11729382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
    Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
    Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High
    Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K
    Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.
    Wu R; Sarkar J; Tokumaru Y; Takabe Y; Oshi M; Asaoka M; Yan L; Ishikawa T; Takabe K
    Am J Cancer Res; 2022; 12(2):504-520. PubMed ID: 35261783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma.
    Chida K; Oshi M; Roy AM; Yachi T; Nara M; Yamada K; Matsuura O; Hashizume T; Endo I; Takabe K
    Surgery; 2023 Aug; 174(2):307-314. PubMed ID: 37198038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAD51 High-Expressed Hepatocellular Carcinomas are Associated With High Cell Proliferation.
    Takahashi K; Yan L; An N; Chida K; Tian W; Oshi M; Takabe K
    J Surg Res; 2024 Aug; 302():250-258. PubMed ID: 39111128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
    Daamen LA; van Goor IWJM; Schouten TJ; Dorland G; van Roessel SR; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):708-716. PubMed ID: 33323293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Cancer Surgery: The New R-status Counts.
    Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
    Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High miR-200c expression is associated with suppressed epithelial-mesenchymal transition, TGF-β signaling and better survival despite enhanced cell proliferation in gastric cancer patients.
    Shichiri K; Oshi M; Ziazadeh D; Endo I; Takabe K
    Am J Cancer Res; 2023; 13(7):3027-3040. PubMed ID: 37560006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.